Potential Role for IL-7 in Fas-Mediated T Cell Apoptosis During HIV Infection

Department of Microbiology and Tumor Biology Center, Karolinska Institutet, Stockholm, Sweden.
The Journal of Immunology (Impact Factor: 4.92). 04/2007; 178(8):5340-50. DOI: 10.4049/jimmunol.178.8.5340
Source: PubMed


IL-7 promotes survival of resting T lymphocytes and induces T cell proliferation in lymphopenic conditions. As elevated IL-7 levels occur in HIV-infected individuals in addition to high Fas expression on T cells and increased sensitivity to Fas-induced apoptosis, we analyzed whether IL-7 has a regulatory role in Fas-mediated T cell apoptosis. We show that IL-7 up-regulates Fas expression on naive and memory T cells through a mechanism that involves translocation of Fas molecules from intracellular compartments to the cell membrane. IL-7 induced the association of Fas with the cytoskeletal component ezrin and a polarized Fas expression on the cell surface. The potential role of IL-7 in Fas up-regulation in vivo was verified in IL-7-treated macaques and in HIV-infected or chemotherapy treated patients by the correlation between serum IL-7 levels and Fas expression on T cells. IL-7 treatment primed T cells for Fas-induced apoptosis in vitro and serum IL-7 levels correlated with the sensitivity of T cells to Fas-induced apoptosis in HIV-infected individuals. Our data suggest an important role for IL-7 in Fas-mediated regulation of T cell homeostasis. Elevated IL-7 levels associated with lymphopenic conditions, including HIV-infection, might participate in the increased sensitivity of T cells for activation-induced apoptosis.

Download full-text


Available from: Eva Rajnavolgyi, Sep 30, 2015
27 Reads
  • Source
    • "The IL-7Rα also plays an important role in signal transmission required for the development of the secondary lymphoid system [17]. At the same time it stimulates Fas antigen expression, by increasing T cell sensitivity to apoptosis [18]. "
    [Show abstract] [Hide abstract]
    ABSTRACT: The hypertrophic adenoid may promote chronic suppurative otitis media in children as it fulfills its immune function. The number of lymphocytes in the adenoid and their cooperation in the immune response depend of on their proliferation and migration to the effector sites. Interleukin 7 (IL-7) is essential for the normal development and function lymphocytes. IL-7 plays pivotal role for activation and proliferation of T and B cells. The heterodimeric interleukin-7 receptor (IL-7R) is composed of the IL-7Rα (127) and the common cytokine receptor γc (CD132). The aim of this study was to evaluate the percentage of lymphocytes T (CD4(+) and CD8(+)) with IL-7R (CD127 and CD132) expression in hypertrophic adenoid in children suffering with otitis media with effusion for a duration of 3 months. Adenoid excised due to hypertrophy with or without chronic otitis media with effusion was used as study material. CD4(+) CD127(+), CD4(+)132(+), CD8(+)CD127(+) and CD8(+)CD132(+) cell subpopulations were identified using monoclonal antibodies and flow cytometry. The percentage of CD4(+) and CD8(+) T cells with CD127 receptor expression in hypertrophic adenoid of children with otitis media with effusion was statistically significantly higher than in hypertrophic adenoid group. The percentage of CD4(+) T cells with CD132 expression in the study group was statistically significantly higher than in the reference group. The percentage of CD8(+) T cells with CD132(+) expression was not statistically different in both groups. The increased percentage of T lymphocytes with IL-7R expression (CD127 and CD132) in hypertrophic adenoid seems to influence the quantity of lymphocytes and upset the immunological function of tonsils which can influence the course of otitis media with effusion.
    Archives of Oto-Rhino-Laryngology 03/2012; 269(7):1821-5. DOI:10.1007/s00405-012-1977-8 · 1.55 Impact Factor
  • Source
    • "IL-7 signaling is transmitted by a receptor composed by the IL-7Rα together with the common γ-chain, a subunit shared by several cytokines, including IL-2, IL-4, IL-7, IL-15 and IL-21. Since IL-2 and IL-15 share the ability of IL-7 to induce CD95 expression on resting T cells [9], we tested whether the different γ-chain using cytokines could induce IFN-γ production by T cells. T cells were cultured for five days in the presence of the above mentioned γ-chain using cytokines and the culture supernatant was tested for IFN-γ concentration. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Interleukin-7 (IL-7) concentrations are increased in the blood of CD4+ T cell depleted individuals, including HIV-1 infected patients. High IL-7 levels might stimulate T cell activation and, as we have shown earlier, IL-7 can prime resting T cell to CD95 induced apoptosis as well. HIV-1 infection leads to B cell abnormalities including increased apoptosis via the CD95 (Fas) death receptor pathway and loss of memory B cells. Peripheral B cells are not sensitive for IL-7, due to the lack of IL-7Ra expression on their surface; however, here we demonstrate that high IL-7 concentration can prime resting B cells to CD95-mediated apoptosis via an indirect mechanism. T cells cultured with IL-7 induced high CD95 expression on resting B cells together with an increased sensitivity to CD95 mediated apoptosis. As the mediator molecule responsible for B cell priming to CD95 mediated apoptosis we identified the cytokine IFN-γ that T cells secreted in high amounts in response to IL-7. These results suggest that the lymphopenia induced cytokine IL-7 can contribute to the increased B cell apoptosis observed in HIV-1 infected individuals.
    PLoS ONE 12/2011; 6(12):e28629. DOI:10.1371/journal.pone.0028629 · 3.23 Impact Factor
  • Source
    • "Briefly, IL-7 signaling triggers negative feedback to IL-7Rα transcription in order to prevent depletion by activated expanding cells, and ensure that IL-7 is available to other IL-7 dependent lymphocytes. The amounts of IL-7 available vary also depending on the clearance by the receptors present on lymphoid cells (Fluur et al., 2007). Therefore, in lymphopenic patients like that found early after bone marrow transplantation (BMT), blood levels of IL-7 are high. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Interleukin (IL)-7 is required for T-cell development as well as for the survival and homeostasis of mature T-cells. In the thymus, the double negative (DN) CD4(-) CD8(-) thymocyte progenitor transition into double positive CD4+ CD8+ cells requires Notch and IL-7 signaling. Importantly, IL-7 seems to have a dose effect on T-cell development and, at high doses, DN progression is blocked. Naïve T-cells in the thymus, and after their exit to the periphery, are dependent on IL-7 and TCR signaling for survival. Upon antigen exposure, they proliferate and differentiate into memory T-cells. Because IL-7 intervenes at all stages of T-cell development and maintenance, it has been introduced recently into clinical trials as an immunotherapeutic agent for cancer patients (of particular note, those who had undergone T-cell depleting therapy) in an attempt to increase their population sizes of CD4+ and CD8+ cells overall, and specifically of CD8+ (CD45RA+)CCR7+ and/or CD27+), CD4+ (CD45RA+CD31+), and CD4+ central memory T-cells (CD45RA(-)CCR7+). Interestingly, IL-7 in humans induced a preferential expansion of naïve T-cells, resulting in a broader T-cell repertoire than before the treatment; this effect was independent of age. This suggests that IL-7 therapy could enhance immune responses in patients with limited naïve T-cell numbers as in aged patients or after disease-induced or iatrogenic T-cell depletion. This overview highlights the role of IL-7 on T-cells in mice and humans.
    Journal of Immunotoxicology 12/2009; 7(1):1-7. DOI:10.3109/15476910903453296 · 2.05 Impact Factor
Show more